Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 12, 2020

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
SARS-CoV
Interventions
DIAGNOSTIC_TEST

EasyCov POC

Saliva samples will be collected according to the sampling protocol defined each for EASYCOV test. The EasyCoV test will be performed at the beginning of the study before obtaining the routine RT- PCR test results. The operators performing this test will be blinded from the routine RT-PCR results.

Trial Locations (1)

Unknown

Istanbul University Istanbul Faculty of Medicine (ITF), Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Istanbul University

OTHER

lead

Firalis SA

INDUSTRY

NCT04583319 - Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection | Biotech Hunter | Biotech Hunter